Mass General Cancer Center

Boston, Massachusetts 02114-2696

6 studies enrolling now · 10 studies all time

What they study most

Advanced Solid Tumors, Advanced Urothelial Carcinoma, Advanced or Metastatic Solid Tumors, Biochemically Recurrent Prostate Cancer, Breast Neoplasms, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, FGF19 Gene Amplification, FGF19 Gene Overexpression, FGFR Gene Alterations

Studies at this site

• A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations — Recruiting now
• A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma — Recruiting now
• A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies — Recruiting now
• Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed
• Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer — Starting soon
• A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide — Completed
• A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer — Completed